Egr-1 upregulates OPN through direct binding to its promoter and OPN upregulates Egr-1 via the ERK pathway

Molecular and Cellular Biochemistry

Volumn 332, Issue 1-2, 2009, Pages 77-84

  Liu, Qi Feng ^a   Yu, Hong Wei ^a   Liu, Gui Nan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

DNA enzyme; Egr 1; Osteopontin; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; EARLY GROWTH RESPONSE PROTEIN 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; PROMOTER REGIONS, GENETIC; RATS; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 70450260687     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0176-4     Document Type: Article

References (39)

1. PJ Wiegman WL Barry JA Mcpherson, et al. 2000 All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: afavorable effect on vessel remodeling Arterioscler Thormb Vasc Biol 20 89 95
2. M Stula HD Orzechowski S Gschwend, et al. 2000 Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells Mol Cell Biochem 210 101 108 10.1023/A:1007126218740 10.1023/A:1007126218740 10976763
3. RH Luan GL Jia W Li, et al. 2003 Inhibition of vascular smooth muscle cell proliferation by specific c-myc mRNA cleaving hammerhead ribozyme J Fourth Mil Med Univ 24 517 521
4. RS Schwartz TD Henry 2002 Pathophysiology of coronary artery restenosis Rev Cardiovasc Med 3 suppl 5 S4 S9 12478229
5. JF Bian BG Zhang HS Qian, et al. 2000 Antisense oligonucleotide inhibits proliferation of vascular smooth muscle cells J Fourth Mil Med Univ 21 1492 1494
6. G Thiel G Cibelli 2002 Regulation of life and death by the zinc finger transcription factor Egr-1 J Cell Physiol 193 287 292 10.1002/jcp.10178 10.1002/jcp.10178 12384981 (Pubitemid 35265949)
7. LM Khachigian 2006 Early growth response-1 in cardiovascular pathobiology Circ Res 98 186 191 10.1161/01.RES.0000200177.53882.c3 10.1161/01.RES. 0000200177.53882.c3 16456111 (Pubitemid 43755349)
8. Y Takahashi Y Fujioka T Takahashi, et al. 2005 Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells Life Sci 77 670 682 10.1016/j.lfs.2005.01.012 10.1016/j.lfs.2005.01.012 15921998 (Pubitemid 40726354)
9. B Du C Fu KC Kent, et al. 2000 Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor J Biol Chem 275 39039 39047 10.1074/jbc.M005159200 10.1074/jbc. M005159200 10982796 (Pubitemid 32058917)
10. M Fang SA Wee K Ronski, et al. 2000 Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases Genomic Med 1 75 85 10.1007/s11568-007-9010-9 10.1007/s11568-007-9010-9
11. GN Liu YX Teng W Yan 2008 Transfected synthetic DNA enzyme gene specifically inhibits Egr-1 gene expression and reduces neointimal hyperplasia following balloon injury in rats Int J Cardiol 129 118 124 10.1016/j.ijcard. 2007.11.066 10.1016/j.ijcard.2007.11.066 18242730
12. H Okamoto 2007 Osteopontin and cardiovascular system Mol Cell Biochem 300 1 7 10.1007/s11010-006-9368-3 10.1007/s11010-006-9368-3 17136480 (Pubitemid 46881810)
13. L Liaw DM Lombardi MM Almeida, et al. 1997 Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation Arterioscler Thromb Vasc Biol 17 188 193 9012655
14. Y Takami MB Russell C Gao, et al. 2007 Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells Surgery 142 163 169 10.1016/j.surg.2007.02.015 10.1016/j.surg.2007.02.015 17689681 (Pubitemid 47198662)
15. A Fernández-Alvarez G Tur G López-Rodas, et al. 2008 Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors FEBS Lett 582 177 184 10.1016/j.febslet.2007.11.083 10.1016/j.febslet.2007.11.083 18068676
16. P Zhang KM Tchou-Wong M Costa 2007 Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter Cancer Res 67 9125 9133 10.1158/0008-5472.CAN-07-1525 10.1158/0008-5472.CAN-07-1525 17909017 (Pubitemid 47535898)
17. H Rangaswami A Bulbule GC Kundu 2006 Nuclear factor inducing kinase: a key regulator in osteopontin-induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation Glycoconjug J 23 221 232 10.1007/s10719-006-7927-1 10.1007/s10719-006-7927-1 (Pubitemid 43725201)
18. SS Nerurkar AR Olzinski KS Frazier, et al. 2007 P38 MAPK inhibitors suppress biomarkers of hypertension end organ damage, osteopontin and plasminogen activator inhibitor-1 Biomarkers 2 87 112 10.1080/13547500600944930 (Pubitemid 46562628)
19. Y Moon H Yang YB Kim 2007 Up-regulation of early growth response gene 1 (EGR-1) via ERK signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells Toxicol Appl Pharmacol 223 155 163 10.1016/j.taap.2007.04.018 10.1016/j.taap.2007.04.018 17599376 (Pubitemid 47348058)
20. SY Shin JH Lee B Min, et al. 2006 The translation inhibitor anisomycin induces Elk-1-mediated transcriptional activation of egr-1 through multiple mitogen- activated protein kinase pathways Exp Mol Med 38 677 685 17202844
21. M Guha MA O'Connell R Pawlinski, et al. 2001 Lipopolysaccharide activation of the MEK-ERK pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression Blood 98 1429 1439 10.1182/blood.V98.5.1429 10.1182/blood.V98.5.1429 11520792
22. C Wang S Dostanic N Servant, et al. 2004 Egr-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo Cardiovasc Res 65 187 194 10.1016/j.cardiores.2004.09.026 10.1016/j.cardiores.2004.09.026
23. H Zhang GK Hunter HA Goldberg, et al. 2007 An integrated procedure of selective injection, sample stacking and fractionation of phosphopeptides for MALDI MS analysis Anal Chim Acta 581 268 280 10.1016/j.aca.2006.08.017 10.1016/j.aca.2006.08.017 17386453 (Pubitemid 44838454)
24. H Yasumoto S Kim Y Zhan, et al. 2001 Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats Gene Ther 8 1682 1689 10.1038/sj.gt.3301590 11892835 (Pubitemid 34030701)
25. M Kume K Komori T Matsumoto, et al. 2002 Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries Circulation 105 1226 1232 10.1161/hc1002.104903 10.1161/hc1002.104903 11889018 (Pubitemid 34225825)
26. M Bryant GM Drew P Houston, et al. 2000 Tissue repair with a therapeutic transcription factor Hum Gene Ther 11 2143 2158 10.1089/104303400750001444 10.1089/104303400750001444 11044915 (Pubitemid 30778416)
27. P Religa K Bojakowski Z Gaciong, et al. 2003 Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins Mol Cell Biochem 249 75 83 10.1023/A:1024755210105 10.1023/A:1024755210105 12956401 (Pubitemid 37021032)
28. F Blaschke D Bruemmer RE Law 2004 Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis Rev Endocr Metab Disord 5 249 254 10.1023/B:REMD.0000032413.88756.ee 10.1023/B:REMD.0000032413.88756.ee 15211096 (Pubitemid 38903582)
29. RG Fahmy LM Khachigian 2007 Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1 J Cell Biochem 100 1526 1535 10.1002/jcb.21145 10.1002/jcb.21145 17171647 (Pubitemid 46515584)
30. YM Zhang GG Shi Z Tang, et al. 2006 Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and Egr-1 expression in rat Acta Biochim Biophys Sin 38 435 441 10.1111/j.1745-7270.2006.00180.x 10.1111/j.1745-7270.2006.00180.x 16761102 (Pubitemid 43894143)
31. Y Lin X Chen Z Yan, et al. 2006 Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice Mol Cell Biochem 285 69 78 10.1007/s11010-005-9056-8 10.1007/s11010-005-9056-8 16477377
32. C Missihoun D Zisa A Shabbir, et al. 2009 Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy Mol Cell Biochem 321 45 52 10.1007/s11010-008-9908-0 10.1007/s11010-008-9908-0 18726675
33. L Wu Y Wu Y Lin, et al. 2007 Osteogenic differentiation of adipose derived stem cells promoted by overexpression of osterix Mol Cell Biochem 301 83 92 10.1007/s11010-006-9399-9 10.1007/s11010-006-9399-9 17206379 (Pubitemid 46895148)
34. S Ashkar GF Weber V Panoutsakopoulou, et al. 2000 Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 860 864 10.1126/science.287.5454.860 10.1126/science.287.5454.860 10657301 (Pubitemid 30084330)
35. DT Denhardt X Guo 1993 Osteopontin: a protein with diverse functions FASEB J 7 1475 1482 8262332
36. ER Mohler III LP Adam P McClelland, et al. 1997 Detection of osteopontin in calcified human aortic valves Arterioscler Thromb Vasc Biol 17 547 552 9102175
37. K Boström 2007 Osteopontin a missing link in PDGF-induced smooth muscle cell migration Cardiovasc Res 75 634 635 10.1016/j.cardiores.2007.06.031 10.1016/j.cardiores.2007.06.031 17643404 (Pubitemid 47238747)
38. S Jalvy MA Renault LL Leen, et al. 2007 Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration Cardiovasc Res 75 738 747 10.1016/j.cardiores.2007.05.019 10.1016/j.cardiores. 2007.05.019 17574222 (Pubitemid 47238739)
39. V Alvarez P González AI Corao, et al. 2008 The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease Alzheimer Dis Assoc Disord 22 177 180 10.1111/j.1744-313X.2007.00671.x 10.1097/WAD.0b013e3181572046 18525291